Presentation is loading. Please wait.

Presentation is loading. Please wait.

Leflunomide as adjuvant treatment of dermatomyositis

Similar presentations


Presentation on theme: "Leflunomide as adjuvant treatment of dermatomyositis"— Presentation transcript:

1 Leflunomide as adjuvant treatment of dermatomyositis
J. Scott Boswell, MD, Melissa I. Costner, MD  Journal of the American Academy of Dermatology  Volume 58, Issue 3, Pages (March 2008) DOI: /j.jaad Copyright © 2008 American Academy of Dermatology, Inc. Terms and Conditions

2 Fig 1 A, Face and B, hands of patient 1 before treatment with leflunomide. Journal of the American Academy of Dermatology  , DOI: ( /j.jaad ) Copyright © 2008 American Academy of Dermatology, Inc. Terms and Conditions

3 Fig 2 A, Face and B, hands of patient 1 after 1 year of treatment with leflunomide. Journal of the American Academy of Dermatology  , DOI: ( /j.jaad ) Copyright © 2008 American Academy of Dermatology, Inc. Terms and Conditions

4 Fig 3 Timeline of systemic therapy for patients 1 to 3. AZA, Azathioprine; bid, twice a day; DM, dermatomyositis; HCQ, hydroxychloroquine; LEF, leflunomide; MTX, methotrexate; PRED, prednisone; qd, 4 times a day; qw, q week; QUIN, quinacrine. Journal of the American Academy of Dermatology  , DOI: ( /j.jaad ) Copyright © 2008 American Academy of Dermatology, Inc. Terms and Conditions


Download ppt "Leflunomide as adjuvant treatment of dermatomyositis"

Similar presentations


Ads by Google